샘플 요청 목록

 카트 문의
시장보고서
상품코드
1529812

세계의 산소 요법 시장 - 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Oxygen Therapy Market Size, Share & Trends Analysis Report By Product (Oxygen Source Equipment, Oxygen Delivery Devices), By Application, By End-use (Home Healthcare, Non-Home Healthcare), By Region, And Segment Forecasts, 2024 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

산소 요법 시장의 성장과 동향 :

Grand View Research Inc.의 최신 보고서에 따르면 세계 산소 요법 시장 규모는 2030년까지 541억 4,000만 달러에 달했으며, 2024-2030년의 CAGR은 6.83%로 확대될 것으로 예측되고 있습니다.

만성 폐색성 폐질환(COPD), 천식, 폐색성 수면 무호흡증후군과 같은 주요 호흡기 질환의 유병률 증가는 시장 성장 촉진요인으로 충격이 큽니다. WHO의 추정에 따르면 천식 및 기타 호흡기 질환의 유병률이 세계적으로 상승한 결과, 전술한 질환을 치료하는 임상적 긴급성이 높아져, 제1선택 치료로서, 또한 다양한 용도에서의 보조 적 치료로서 산소 요법 수요가 높아질 것으로 예상됩니다.

게다가 기술적 진보는 암과 당뇨병과 같은 광범위한 새로운 용도에 성장 기회를 가져올 것으로 예상됩니다. 예를 들어 유량을 절약하고 조정하기 위해 유량 센서를 전달 장치에 통합하면 환자의 편안함과 치료 성적을 향상시킬 수 있습니다. 게다가 가정용 의료 솔루션에 대한 관심과 모바일 운송 장치의 개발이 결합되어 산업 성장에 큰 영향을 미치고 있습니다. 앞서 언급한 요인들은 예측 기간 동안 시장 성장에 기여하는 주요 요인으로 작용할 것으로 예상됩니다.

COVID-19의 유행은 산소 치료 장비 시장에 긍정적인 영향을 미칩니다. 이 큰 유행은 특히 COVID-19를 앓고있는 병원 환자가 급증했을 때 산소 수요를 크게 증가 시켰습니다. 또한 COVID-19 환자의 많음에 따라 병원의 산소 공급이 압박되고 있습니다. 따라서 의료 부문에서 산소 요법 장비에 대한 수요가 증가하고 있으며, 가까운 미래에 상당히 계속 증가할 것으로 예상됩니다. 각국 정부는 지방의 의료 시설의 확충에 힘을 쏟고 있습니다. 향후 인프라 정비 프로젝트에 따라 의료용 산소 수요가 대폭 증가할 것으로 예상됩니다.

산소 요법 시장 보고서 하이라이트

  • 산소 공급 장치 부문은 사용률이 높고, 액체 압축 가스 및 농축기 등 다양한 형태로 폭넓게 이용할 수 있기 때문에 2023년에 가장 큰 점유율을 차지했습니다.
  • 산소 공급 장치는 산소 요법 설정의 필수적인 부분이기 때문에 유리한 성장률이 예상되며 예측 기간 동안 전체 시장 성장에 기여합니다.
  • 산소 농축기는 응급 의료, 외래 및 재택 환경에서 휴대용 농축기의 인기 상승과 채용으로 2023년에 압도적인 점유율을 획득했습니다.
  • 산소 마스크는 전달 시스템의 필수적인 단위이기 때문에 환자의 생리적 요구에 따라 특수 마스크의 가용성이 높기 때문에 2023년 주요 점유율을 차지했습니다.
  • 재택치료는 장기적인 비용 효율성과 기동성 향상과 같은 관련 이점에 의해 크게 성장할 것으로 예측되며, 예측 기간 동안 수요를 촉진하고 있습니다.
  • 또한 미국 재택치료 협회(American Association for Homecare)와 같은 재택치료에 대한 인식 향상과 강화를 위한 조직의 존재는 향후 시장에 성장 기회를 가져올 것으로 예상됩니다.
  • 업계 각사는 보다 큰 시장 점유율을 얻기 위해 신제품 개척, 기술 혁신, 제휴, M&A 등의 전략을 채용하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 산소요법 시장의 변수, 동향, 범위

  • 시장 세분화 및 범위
  • 시장 계통의 전망
  • 침투와 성장의 전망 매핑
  • 규제 프레임워크
  • 시장 역학
  • 산소 요법 시장 분석 도구 : Porter's Five Forces 분석
  • PESTEL 분석
  • COVID-19의 현상과 장래에 대한 영향 분석

제4장 산소요법 시장 : 제품별, 추정·동향 분석

  • 제품의 변동 분석, 2018-2030년
  • 산소 요법 시장 점유율 분석, 2023년과 2030년
  • 산소 실린더
  • 산소 공급 장치

제5장 산소 요법 시장 : 용도별, 추정·동향 분석

  • 용도의 변동 분석, 2018-2030년
  • 산소 요법 시장 점유율 분석, 2022년과 2030년
  • 만성 폐색성 폐질환
  • 천식
  • 폐쇄수면무호흡
  • 호흡 곤란 증후군
  • 낭포성 섬유증
  • 폐렴
  • 기타

제6장: 산소 요법 시장 : 최종 용도별, 추정·동향 분석

  • 최종 용도의 변동 분석, 2018-2030년
  • 산소 요법 시장 점유율 분석, 2022년과 2030년
  • 재택치료
    • 시장 추정·예측, 2018-2030년
  • 재택치료 이외
    • 시장 추정·예측, 2018-2030년

제7장: 지역 추정·동향 분석, 2018-2030년(100만 달러)

  • 지역 시장 현황
  • 지역별 시장 점유율 분석, 2022년과 2030년
  • 북미
    • 북미 시장 추정·예측, 2018-2030년
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 유럽 시장 추정·예측, 2018-2030년
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 스웨덴
    • 덴마크
    • 노르웨이
  • 아시아태평양
    • 아시아태평양 시장 추정·예측, 2018-2030년
    • 일본
    • 중국
    • 인도
    • 한국
    • 싱가포르
    • 호주
    • 태국
  • 라틴아메리카
    • 라틴아메리카 시장 추정·예측, 2018-2030년
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 중동 및 아프리카 시장 추정·예측, 2018-2030년
    • 남아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제8장 경쟁 프로파일

  • Ventec Life Systems, Inc.(Subsidiary of React Health-includes the Respiratory Product Line from Invacare Corporation)
  • Inogen, Inc.
  • IUC Medical(Smiths Medical)
  • HERSILL SL
  • OMRON Healthcare
  • GE Healthcare
  • Fisher &Paykel Healthcare Limited
  • Respironics(a subsidiary of Koninklijke Philips NV)
  • Tecno-Gaz Industries
  • Allied Healthcare Products, Inc.
  • Teleflex Incorporated
  • Chart Industries
  • DeVilbiss Healthcare(a subsidiary of Drive Medical)
  • Dragerwerk AG &Co. KGaA
  • Linde
  • Caire Medical(Niterra Co., Ltd.에 의해 인수, 구사명 NGK SPARK PLUG CO., LTD.)
  • Rhythm Healthcare
  • ResMed

제9장 경쟁 구도

  • 기존 시장 진출기업의 철수 전략과 시장 경쟁에 미치는 영향
    • Invacare Corporation
    • Koninklijke Philips NV
  • 추정 기업 시장 포지션/점유율 분석
JHS 24.08.22

Oxygen Therapy Market Growth & Trends:

The global oxygen therapy market size is expected to reach USD 54.14 billion by 2030, according to a new report by Grand View Research Inc., expanding at a CAGR of 6.83% from 2024 to 2030. The increasing prevalence of major respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and obstructive sleep apnea, is a high-impact rendering driver of the market. As per the estimates of the WHO, a consequential global rise in the prevalence of asthma and other respiratory disorders is expected to heighten clinical urgency to treat the aforementioned disorders and is expected to boost the demand for oxygen therapy as the first-line treatment and as a supplement in various applications.

Moreover, technological advancements are anticipated to provide growth opportunities in a wide range of new applications such as cancer and diabetes. For instance, incorporation of flow sensors in delivery devices to conserve and regulate the flow enables greater patient comfort and outcomes. Furthermore, the increasing focus on home healthcare solutions, coupled with the development of portable delivery devices, is significantly impacting industry growth. These aforementioned factors are expected to serve as key factors contributing to the growth of the market over the forecast period.

The Covid-19 pandemic has positively impacted the market for O2 therapy devices. Due to the outbreak, oxygen demand has increased significantly, especially during the spikes in patients at hospitals suffering from Covid-19. Additionally, pressure on oxygen supplies at hospitals has been caused by a large number of Covid-19 patients. Therefore, the demand for O2 therapy devices in the healthcare sector has increased and will continue to increase significantly in the near future. The governments of various countries are focusing on expanding healthcare facilities in rural areas. With the upcoming infrastructural projects, the demand for medical O2 is expected to increase substantially.

Oxygen Therapy Market Report Highlights:

  • The oxygen source equipment segment held the largest share in 2023 owing to its high usage rate and wide-scale availability in various forms such as liquid compressed gas, and concentrators
  • Oxygen delivery devices are expected to grow at a lucrative rate being an indispensable part of the oxygen therapy set-ups, thereby contributing to the overall market growth during the forecast period
  • Oxygen concentrators captured a dominant share in 2023 owing to rising popularity and adoption of portable concentrators in emergency medicine, ambulatory, and home settings
  • Oxygen masks accounted for a leading share in 2023 as a consequence of being the indispensable unit of the delivery system and greater availability of specialty masks as per the patient's physiological needs
  • Home healthcare is anticipated to grow lucratively owing to associated benefits such as long-term cost efficiency and increased mobility, propelling the demand over the forecast period
  • Moreover, the presence of organizations such as the American Association for Homecare to promote awareness and strengthen home healthcare is expected to provide growth opportunities to the market in the future
  • Industry players are adopting strategies such as new product development, technological innovations, collaborations, and mergers & acquisitions to acquire a greater market share

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information/Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
    • 1.6.2 Top Down Market Estimation
    • 1.6.3 Region Based Segment Share Calculation
    • 1.6.4 Global Market: CAGR Calculation
  • 1.7 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Oxygen Therapy Market Summary
    • 2.1.1 Segment Outlook
    • 2.1.2 Regional Outlook
    • 2.1.3 Competitive Outlook
  • 2.2 Market Snapshot, 2023

Chapter 3 Oxygen Therapy Market Variables Trends & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Segment Scope
  • 3.2 Market Lineage Outlook
    • 3.2.1 Ancillary Market Outlook
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Regulatory Framework
    • 3.4.1 Europe
      • 3.4.1.1 UK
    • 3.4.2 North America
      • 3.4.2.1 U.S.
      • 3.4.2.2 Canada
    • 3.4.3 Asia Pacific
      • 3.4.3.1 India
      • 3.4.3.2 China
      • 3.4.3.3 Australia
  • 3.5 Market Dynamics
    • 3.5.1 Market Driver Analysis
      • 3.5.1.1 Rising Prevalence of Respiratory Diseases
      • 3.5.1.2 Launch of New Generation Product and Increasing Business Expansion
      • 3.5.1.3 Growing Preference Towards Home-Based Oxygen Therapy
      • 3.5.1.4 Rising Initiative By Organizations Regarding Respiratory Diseases
    • 3.5.2 Market Restraints Analysis
      • 3.5.2.1 Complex Regulatory Framework
  • 3.6 Oxygen Therapy Market Analysis Tools: Porter's
    • 3.6.1 Bargaining Power of Suppliers: Low
    • 3.6.2 Bargaining Power of Buyers: High
    • 3.6.3 Threat of Substitutes: High
    • 3.6.4 Threat of New Entrants: High
    • 3.6.5 Industry Rivalry: High
  • 3.7 PESTEL Analysis
    • 3.7.1 Political & Legal
    • 3.7.2 Economic
    • 3.7.3 Social
    • 3.7.4 Technological
    • 3.7.5 Environmental
  • 3.8 COVID-19 Current and Future Impact Analysis
    • 3.8.1 Current Impact Analysis
    • 3.8.2 Future Impact Analysis
    • 3.8.3 COVID-19 Impact On Notable Market Players
      • 3.8.3.1 Philips N.V.
      • 3.8.3.2 Fisher & Paykel Healthcare
      • 3.8.3.3 GE Healthcare

Chapter 4 Oxygen Therapy Market: Product Estimates & Trend Analysis

  • 4.1 Product Movement Analysis, 2018 - 2030 (USD Million)
  • 4.2 Oxygen Therapy Market Share Analysis, 2023 & 2030
  • 4.3 Oxygen Source Equipment
    • 4.3.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2 Oxygen Cylinders
      • 4.3.2.1 Market Insight
      • 4.3.2.2 Competitive Insight
      • 4.3.2.3 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.4 Fixed Oxygen Cylinders
      • 4.3.2.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.5 Portable Oxygen Cylinders
      • 4.3.2.5.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3 Oxygen Concentrator
      • 4.3.3.1 Market Insight
      • 4.3.3.2 Competitive Insight
      • 4.3.3.3 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.4 Fixed Oxygen Concentrator
      • 4.3.3.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.5 Portable Oxygen Concentrator
      • 4.3.3.5.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4 Liquid Oxygen System
      • 4.3.4.1 Market Insight
      • 4.3.4.2 Competitive Insight
      • 4.3.4.3 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5 PAP Devices
      • 4.3.5.1 Market Insight
      • 4.3.5.2 Competitive Insight
      • 4.3.5.3 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.5.4 CPAP Devices
      • 4.3.5.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.5.5 APAP Devices
      • 4.3.5.5.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.5.6 Bi-PAP Devices
      • 4.3.5.6.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4 Oxygen Delivery Devices
    • 4.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2 Oxygen Mask
      • 4.4.2.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3 Nasal Cannula
      • 4.4.3.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4 Venturi Mask
      • 4.4.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5 Non-Rebreather Mask
      • 4.4.5.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6 Bag Valve Mask
      • 4.4.6.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.7 CPAP Mask
      • 4.4.7.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.8 Others
      • 4.4.8.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Oxygen Therapy Market: Application Estimates & Trend Analysis

  • 5.1 Application Movement Analysis, 2018 - 2030 (USD Million)
  • 5.2 Oxygen Therapy Market Share Analysis, 2022 & 2030
  • 5.3 Chronic Obstructive Pulmonary Disease
    • 5.3.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4 Asthma
    • 5.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Obstructive Sleep Apnea
    • 5.5.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6 Respiratory Distress Syndrome
    • 5.6.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7 Cystic Fibrosis
    • 5.7.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8 Pneumonia
    • 5.8.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9 Others
    • 5.9.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6: Oxygen Therapy Market: End Use Estimates & Trend Analysis

  • 6.1 End use Movement Analysis, 2018 - 2030 (USD Million)
  • 6.2 Oxygen Therapy Market Share Analysis, 2022 & 2030
  • 6.3 Homecare
    • 6.3.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Non-Homecare
    • 6.4.1 Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7: Regional Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 7.1 Regional Market Snapshot
  • 7.2 Regional Market Share Analysis, 2022 & 2030
  • 7.3 North America
    • 7.3.1 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2 U.S.
      • 7.3.2.1 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 Canada
      • 7.3.3.1 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4 Mexico
      • 7.3.4.1 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4 Europe
    • 7.4.1 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2 Germany
      • 7.4.2.1 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3 France
      • 7.4.3.1 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4 UK
      • 7.4.4.1 UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5 Italy
      • 7.4.5.1 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6 Spain
      • 7.4.6.1 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7 Sweden
      • 7.4.7.1 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.8 Denmark
      • 7.4.8.1 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.9 Norway
      • 7.4.9.1 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5 Asia Pacific
    • 7.5.1 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2 Japan
      • 7.5.2.1 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3 China
      • 7.5.3.1 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4 India
      • 7.5.4.1 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5 South Korea
      • 7.5.5.1 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6 Singapore
      • 7.5.6.1 Singapore Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7 Australia
      • 7.5.7.1 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8 Thailand
      • 7.5.8.1 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6 Latin America
    • 7.6.1 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2 Brazil
      • 7.6.2.1 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3 Argentina
      • 7.6.3.1 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7 MEA
    • 7.7.1 MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2 South Africa
      • 7.7.2.1 South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3 Saudi Arabia
      • 7.7.3.1 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4 UAE
      • 7.7.4.1 UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5 Kuwait
      • 7.7.5.1 Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Competitive Profiles

  • 8.1 Ventec Life Systems, Inc. (Subsidiary of React Health - includes the Respiratory Product Line from Invacare Corporation)
    • 8.1.1 Company Overview
    • 8.1.2 Financial Performance
    • 8.1.3 Product Benchmarking
    • 8.1.4 Strategic Initiatives
  • 8.2 Inogen, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Performance
    • 8.2.3 Product Benchmarking
    • 8.2.4 Strategic Initiatives
  • 8.3 IUC Medical (Smiths Medical)
    • 8.3.1 Company Overview
    • 8.3.2 Financial Performance
    • 8.3.3 Product Benchmarking
    • 8.3.4 Strategic Initiatives
  • 8.4 HERSILL S.L.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Performance
    • 8.4.3 Product Benchmarking
    • 8.4.4 Strategic Initiatives
  • 8.5 OMRON Healthcare
    • 8.5.1 Company Overview
    • 8.5.2 Financial Performance
    • 8.5.3 Product Benchmarking
    • 8.5.4 Strategic Initiatives
  • 8.6 GE Healthcare
    • 8.6.1 Company Overview
    • 8.6.2 Financial Performance
    • 8.6.3 Product Benchmarking
    • 8.6.4 Strategic Initiatives
  • 8.7 Fisher & Paykel Healthcare Limited
    • 8.7.1 Company Overview
    • 8.7.2 Financial Performance
    • 8.7.3 Product Benchmarking
    • 8.7.4 Strategic Initiatives
  • 8.8 Respironics (a subsidiary of Koninklijke Philips N.V.)
    • 8.8.1 Company Overview
    • 8.8.2 Financial Performance
    • 8.8.3 Product Benchmarking
    • 8.8.4 Strategic Initiatives
  • 8.9 Tecno-Gaz Industries
    • 8.9.1 Company Overview
    • 8.9.2 Financial Performance
    • 8.9.3 Product Benchmarking
    • 8.9.4 Strategic Initiatives
  • 8.10 Allied Healthcare Products, Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Performance
    • 8.10.3 Product Benchmarking
    • 8.10.4 Strategic Initiatives
  • 8.11 Teleflex Incorporated
    • 8.11.1 Company Overview
    • 8.11.2 Financial Performance
    • 8.11.3 Product Benchmarking
    • 8.11.4 Strategic Initiatives
  • 8.12 Chart Industries
    • 8.12.1 Company Overview
    • 8.12.2 Financial Performance
    • 8.12.3 Product Benchmarking
    • 8.12.4 Strategic Initiatives
  • 8.13 DeVilbiss Healthcare (a subsidiary of Drive Medical)
    • 8.13.1 Company Overview
    • 8.13.2 Financial Performance
    • 8.13.3 Product Benchmarking
    • 8.13.4 Strategic Initiatives
  • 8.14 Dragerwerk AG & Co. KGaA
    • 8.14.1 Company Overview
    • 8.14.2 Financial Performance
    • 8.14.3 Product Benchmarking
    • 8.14.4 Strategic Initiatives
  • 8.15 Linde
    • 8.15.1 Company Overview
    • 8.15.2 Financial Performance
    • 8.15.3 Product Benchmarking
    • 8.15.4 Strategic Initiatives
  • 8.16 Caire Medical (Acquired by Niterra Co., Ltd. formerly known as NGK SPARK PLUG CO., LTD.)
    • 8.16.1 Company Overview
    • 8.16.2 Financial Performance
    • 8.16.3 Product Benchmarking
    • 8.16.4 Strategic Initiatives
  • 8.17 Rhythm Healthcare
    • 8.17.1 Company Overview
    • 8.17.2 Financial Performance
    • 8.17.3 Product Benchmarking
    • 8.17.4 Strategic Initiatives
  • 8.18 ResMed
    • 8.18.1 Company Overview
    • 8.18.2 Financial Performance
    • 8.18.3 Product Benchmarking
    • 8.18.4 Strategic Initiatives

Chapter 9 Competitive Landscape

  • 9.1 Exit Strategies of Existing Market Players and Their Impact on Market Competitors
    • 9.1.1. Invacare Corporation
    • 9.1.2. Koninklijke Philips N.V.
  • 9.2 Estimated Company Market Position/Share Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제